Literature DB >> 22283193

Use of the histological pseudocapsule in surgery for Cushing disease: rapid postoperative cortisol decline predicting complete tumor resection.

Stephen J Monteith1, Robert M Starke, John A Jane, Edward H Oldfield.   

Abstract

OBJECT: Subnormal postoperative serum cortisol levels indicate successful surgery and predict long-term remission of Cushing disease. Given the short serum half-lives of adrenocorticotropic hormone (ACTH) and cortisol, it is unclear why the decline in cortisol postoperatively is delayed for 18-36 hours. Furthermore, the relevance of the rate of cortisol drop immediately after surgery has not been investigated.
METHODS: Patient data were analyzed from a prospectively accrued database. After surgery, cortisol replacement was withheld and serum cortisol measurements were obtained every 6 hours until values of 1.0-2.0 μg/dl or less were reached. The authors selected patients in whom serum cortisol dropped to 2 μg/dl or less after surgery (101 patients). Tumor resection was categorized as follows: 1) complete resection using the histological pseudocapsule as a surgical capsule, 2) complete piecemeal resection), 3) known incomplete resection, and 4) total hypophysectomy.
RESULTS: The median time to reach a cortisol level of less than or equal to 2.0 μg/dl was 9.9, 19.4, 25.3, and 29.5 hours with hypophysectomy, pseudocapsule, incomplete resection, and piecemeal techniques, respectively. Pseudocapsule resection produced a faster decline in cortisol than piecemeal techniques (p = 0.0001), but not as rapid a decline as hypophysectomy (p = 0.033).
CONCLUSIONS: Complete resection by other techniques is associated with delayed cortisol decline compared with pseudocapsule surgery, which may represent the product of residual tumor cells and therefore may explain the higher rate of recurrent disease associated with piecemeal techniques. The prompt drop in cortisol after hypophysectomy compared with patients with pseudocapsule surgery suggests that the corticotrophs of the normal gland can secrete ACTH for 10-36 hours after surgery despite prolonged and severe hypercortisolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283193     DOI: 10.3171/2011.12.JNS11886

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

Review 1.  Surgical management of Cushing's disease.

Authors:  Robert F Dallapiazza; Edward H Oldfield; John A Jane
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

2.  Extracapsular en bloc resection in pituitary adenoma surgery.

Authors:  Eui Hyun Kim; Cheol Ryong Ku; Eun Jig Lee; Sun Ho Kim
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

3.  Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.

Authors:  Eliza B Geer; Alejandro Ayala; Vivien Bonert; John D Carmichael; Murray B Gordon; Laurence Katznelson; Ekaterina Manuylova; Ismat Shafiq; Vijaya Surampudi; Ronald S Swerdloff; Michael S Broder; Dasha Cherepanov; Marianne Eagan; Jackie Lee; Qayyim Said; Maureen P Neary; Beverly M K Biller
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

4.  Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.

Authors:  David Asuzu; Grégoire P Chatain; Christina Hayes; Sarah Benzo; Raven McGlotten; Meg Keil; Andrea Beri; Susmeeta T Sharma; Lynnette Nieman; Maya Lodish; Constantine Stratakis; Russell R Lonser; Edward H Oldfield; Prashant Chittiboina
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

5.  Surgical outcome of transsphenoidal surgery in Cushing's disease: a case series of 1106 patients from a single center over 30 years.

Authors:  Congxin Dai; Ming Feng; Bowen Sun; Xinjie Bao; Yong Yao; Kan Deng; Zuyuan Ren; Binghao Zhao; Lin Lu; Renzhi Wang; Jun Kang
Journal:  Endocrine       Date:  2021-08-20       Impact factor: 3.633

Review 6.  Contemporary neurosurgical techniques for pituitary tumor resection.

Authors:  John Y K Lee; Leif-Erik Bohman; Marvin Bergsneider
Journal:  J Neurooncol       Date:  2013-11-22       Impact factor: 4.130

7.  Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.

Authors:  Natasha Ironside; Gregoire Chatain; David Asuzu; Sarah Benzo; Maya Lodish; Susmeeta Sharma; Lynnette Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

8.  Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth.

Authors:  Yakun Yang; Miaomiao Sheng; Fengming Huang; Dechao Bu; Xiaohai Liu; Yong Yao; Congxin Dai; Bowen Sun; Jindong Zhu; Yonghui Jiao; Zhenqing Wei; Huijuan Zhu; Lin Lu; Yi Zhao; Chengyu Jiang; Renzhi Wang
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

9.  Sellar and parasellar lesions: multidisciplinary management.

Authors:  Enzo Emanuelli; Claudia Zanotti; Sara Munari; Maria Baldovin; Gloria Schiavo; Luca Denaro
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

10.  Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.

Authors:  Jon Ramm-Pettersen; Helene Halvorsen; Johan Arild Evang; Pål Rønning; Per Kristian Hol; Jens Bollerslev; Jon Berg-Johnsen; Eirik Helseth
Journal:  BMC Endocr Disord       Date:  2015-10-25       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.